Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients

NCT02990312 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Hiv
Kidney Transplant
HIV Reservoir
CCR5

Interventions

DRUG: Sirolimus + Maraviroc

Sponsor

University of Maryland, Baltimore